Patents by Inventor Bérangère Vasseur-Demarcy

Bérangère Vasseur-Demarcy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy
    Patent number: 11090290
    Abstract: The present invention pertains to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and Clonidine and/or Clonidine derivatives as a sole active ingredient for use in the prevention of skin injury resulting from radiotherapy by transmucocal administration.
    Type: Grant
    Filed: May 10, 2016
    Date of Patent: August 17, 2021
    Assignee: MONOPAR THERAPEUTICS, INC.
    Inventors: Bérangère Vasseur-Demarcy, Pierre Attali
  • Clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of chemotherapy
    Patent number: 10675271
    Abstract: The present invention pertains to specific clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of alkylating agent chemotherapy, other than those resulting from mucosal inflammation. It also pertains to the use of this clonidine and/or clonidine derivative for the manufacture of a pharmaceutical composition intended to prevent and/or alleviate the adverse side effects of alkylating agent chemotherapy, other than those resulting from mucosal inflammation. This invention is further directed to a kit comprising: (a) a clonidine and/or clonidine derivative, and (b) at least one alkylating chemotherapeutic agent, as a combined preparation for simultaneous, separate or sequential use in the treatment of cancer.
    Type: Grant
    Filed: April 17, 2015
    Date of Patent: June 9, 2020
    Assignee: MONOPAR THERAPEUTICS, INC.
    Inventors: Bérangère Vasseur-Demarcy, Pierre Attali
  • CLONIDINE AND/OR CLONIDINE DERIVATIVES FOR USE IN THE PREVENTION AND/OR TREATMENT OF ADVERSE SIDE EFFECTS OF CHEMOTHERAPY
    Publication number: 20180098966
    Abstract: The present invention pertains to specific clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of alkylating agent chemotherapy, other than those resulting from mucosal inflammation. It also pertains to the use of this clonidine and/or clonidine derivative for the manufacture of a pharmaceutical composition intended to prevent and/or alleviate the adverse side effects of alkylating agent chemotherapy, other than those resulting from mucosal inflammation. This invention is further directed to a kit comprising: (a) a clonidine and/or clonidine derivative, and (b) at least one alkylating chemotherapeutic agent, as a combined preparation for simultaneous, separate or sequential use in the treatment of cancer.
    Type: Application
    Filed: April 17, 2015
    Publication date: April 12, 2018
    Inventors: Bérangère Vasseur-Demarcy, Pierre Attali
  • CLONIDINE AND/OR CLONIDINE DERIVATIVES FOR USE IN THE PREVENTION OF SKIN INJURY RESULTING FROM RADIOTHERAPY
    Publication number: 20180098967
    Abstract: The present invention pertains to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and Clonidine and/or Clonidine derivatives as a sole active ingredient for use in the prevention of skin injury resulting from radiotherapy by transmucocal administration.
    Type: Application
    Filed: May 10, 2016
    Publication date: April 12, 2018
    Inventors: Bérangère Vasseur-Demarcy, Pierre Attali